These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effects of extracellular Ca2+ and the intracellular Ca2+ antagonist 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate on rabbit platelet conversion of arachidonic acid into thromboxane.
    Author: Shaw JO.
    Journal: Prostaglandins; 1981 Apr; 21(4):571-9. PubMed ID: 6789402.
    Abstract:
    The regulatory role of Ca2+ on the conversion of arachidonic acid (AA) into thromboxane B2 (TXB2) was examined in washed rabbit platelets, whose secretory processes are known to have requirements for extracellular Ca2+. Varying the extracellular free Ca2+ [Caf2+] concentration from less than 10(-8) M to 10(-3) M had no significant effect on the synthesis of immunoreactive TXB2 by rabbit platelets incubated with 1-4 microM AA. On the other hand, 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate (TMB-8), a putative antagonist of intracellular Ca2+ movement, inhibited AA-stimulated synthesis of TXB2 in a concentration dependent manner--an effect which could be partially overcome by increasing the AA concentration. The TMB-8 inhibition could not be reversed by increasing the [Ca2+f]. Studies examining platelet metabolism of 14C-AA and 14C-prostaglandin H2 demonstrated that TMB-8 inhibited platelet cyclooxygenase, but not thromboxane synthetase. These studies demonstrate the absence of a requirement for [Ca2+f] but suggest the presence of a TMB-8 sensitive intracellular Ca2+ pool in the rabbit platelet synthesis of TXB2 from AA.
    [Abstract] [Full Text] [Related] [New Search]